UE LifeSciences Inc.
Mihir is passionate about addressing global health disparities with rapid commercialization of scientific discoveries and innovation. After seeing his mother-in-law go through breast cancer, he founded UE LifeSciences to enable affordable and scalable access to early diagnosis of cancer, for women everywhere. UE LifeSciences has developed the iBreastExam, a US FDA-cleared, hand-held device that enables health workers to identify non-palpable breast lumps in just a few minutes, without pain or radiation and at a fraction of the cost of a mammogram. After multiple regulatory approvals, over 200,000 women in 12 countries have benefited, many receiving a breast exam for the first time in their life. With over 15 years of dedicated med-tech commercialization experience, Mihir is leading a multidisciplinary team of clinicians, engineers, and scientists to build meaningful, practical and highly scalable innovations as a defense against the rising tide of cancer globally. Mihir is a two-time TED speaker and adjunct faculty at Drexel University’s School of Biomedical Engineering.